... improved cancer-specific quality of life for women following curative treatment for stage I-III gynaecologicalcancer AbstractText: Consecutive women were invited to participate in a randomised controlled study (HNA and care ... professional is cost-effective, acceptable and useful for some women treated for stage I-III gynaecologicalcancer... Keyword: gynaecologicalcancer.
... to validate the Korean-version MSAS-SF in patients with gynecologiccancer AbstractText: We translated the MSAS-SF into Korean and 175 gynecologiccancer inpatients completed the MSAS-SF, Functional Assessment Cancer Therapy-General ... a valid tool for the reliable assessment of patients with gynecologiccancer in Korea Keyword: Gynecologicneoplasm.
Oncology (8) Neoplasms (7), Female Genital Neoplasms (1), more mentions
DescriptorName: OvarianNeoplasms... Abstract: We present an exceptional case of a patient with high-grade serous ovariancancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases ...
Background Vulvarcancer (VC) can be sub-classified by human papilloma virus (HPV ... We comprehensively assessed somatic mutations in a large series of vulvar (pre)cancers... Results Frequent recurrent mutations were identified in HPV negative vulvar (pre)cancers in TP53 (42% and 68%), NOTCH1 (28% and 41%) and ... Mutation frequency in HPV positive vulvar (pre)cancers was significantly lower (p-value = 0.001.
... poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovariancarcinoma harbouring a BRCA mutation or high percentage of genome-wide ... based chemotherapy in patients with high-grade, recurrent, platinum-sensitive ovariancarcinoma.In this randomised, double-blind, placebo-controlled, phase 3 trial ... significantly improved progression-free survival in patients with platinum-sensitive ovariancancer who had achieved a response to platinum-based chemotherapy.
Patients who underwent ovarian, fallopian tube, or peritoneal cancer cytoreductive surgery at an academic tertiary care center from April ... 12/91 [13%]; P=.005) AbstractText: Infection is common after ovariancancer cytoreductive surgery... 5-point surgical site infection prevention bundle in women undergoing ovariancancer operations was associated with dramatically decreased infection rates and lower ...
Oncology (4), Infectious Diseases (2), Anti-Obesity and Weight Loss (1) Infections (11), Ovarian Neoplasms (3), Neoplasms (1), more mentions
... morbidity and overall survival (OS) in patients with advanced epithelial ovariancancer (EOC) treated at a tertiary gynecologiccancer center AbstractText: Exploratory analysis of our prospectively documented tumor registry ... Data of all consecutive patients with stage IIIB-IV ovariancancer who underwent primary cytoreductive surgery (PDS) from January 2000 to ...
Abstract: The aim of this study was to review the surgical and clinical outcomes of intrathoracic and mediastinal surgical cytoreduction in stage IV epithelial ovariancancer (EOC. Relevant articles were identified from MEDLINE and EMBASE. Only analyses or reports that described actual intrathoracic cytoreduction via pleurectomy and/or resection of cardiophrenic/mediastinal lymph nodes were included.
Patients with known ovarian cysts or ovariancancer at time of the index CT examination were excluded ... CI: 0.4%, 1.0%) of 2763 patients were found to have ovariancancer after an average follow-up of 5.1 years ± 3.8 (range ... women with simple-appearing cysts were given a diagnosis of ovariancancer.
... may serve as a unique tumor marker for HPV-associated malignancies, including cervicalcancer... HPV DNA in patients with HPV16- or HPV18-positive metastatic cervicalcancer for potential disease monitoring and treatment-related decision making.In ... HPV ccfDNA was measured in serum samples from 19 metastatic cervicalcancer patients by duplex digital droplet (dd) PCR.
Oncology (7) Neoplasms (7), Uterine Cervical Neoplasms (6), more mentions
Of these clinics, 31 (39.7%) offered both cervicalcancer screening and HPV vaccination, 6 (7.7%) offered cervicalcancer screening only, 21 (26.9%) offered HPV vaccination only, and 20 (25.6%) offered neither cervicalcancer prevention service ... not offering the service, the most commonly reported barrier to cervicalcancer screening was time constraints (25/41, 61.0%); for HPV vaccination ...